Patent Assignment
Reel/Frame 029731/0423
Assignment of Assignor's Interest
Recorded: 2013-01-31
Pages: 9
Assignor
DEUTERIA PHARMACEUTICALS INC
Executed: 2012-12-03
Assignee
DEUTERX, LLC
300 BRICKSTONE SQUARE, SUITE 201, ANDOVER, MASSACHUSETTS, 01810
Covered Properties
(14)
Deuterium-Enriched Bupropion
Application:
60/972,205 →
Deuterium-Enriched Bupropion
Application:
12/196,231 →
Publication:
US 2009/0076161
Deuterium-Enriched Bupropion
Deuterium-Enriched Donepezil
Application:
60/971,892 →
Deuterium-Enriched Prasugrel
Application:
60/971,902 →
Deuterium-Enriched Prasugrel
Deuterium-Enriched Odansetron
Application:
60/972,238 →
Deuterium-Enriched Pioglitazone
Application:
60/975,193 →
Deuterium-Enriched Pioglitazone
2,6-Dioxo-3-Deutero-Piperdin-3-Yl-Isoindoline Compounds
Application:
61/468,179 →
2,6-Dioxo-3-Deutero-Piperdin-3-Yl-Isoindoline Compounds
Deuterium-Enriched Donepezil
Deuterium-Enriched Odansetron
2',6'-Dioxo-3'-Deutero-Piperdin-3-Yl-Isoindoline Compounds
PCT:
PCT/US2012/030870 ↗
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 24, 2008
From: CZARNIK, ANTHONY W
To: PROTIA, LLC
Reel/Frame 021733/0840 →
Assignment of Assignor's Interest
Jul 18, 2011
From: PROTIA, LLC
To: DEUTERIA PHARMACEUTICALS INCE
Reel/Frame 026609/0689 →
Assignment of Assignor's Interest
Jul 3, 2012
From: DEWITT, SHEILA
To: DEUTERIA PHARMACEUTICALS, INC
Reel/Frame 028484/0652 →
Assignment of Assignor's Interest
Jun 7, 2013
From: CZARNIK, ANTHONY W.
To: PROTIA, LLC
Reel/Frame 030564/0147 →
Assignment of Assignor's Interest
Jun 7, 2013
From: PROTIA, LLC
To: DEUTERIA PHARMACEUTICALS, INC.
Reel/Frame 030564/0169 →
Assignment of Assignor's Interest
Feb 27, 2019
From: DEUTERX, LLC
To: POXEL SA
Reel/Frame 048453/0967 →
Assignment of Assignor's Interest
Jan 20, 2026
From: DEUTERX, LLC
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 073523/0608 →